Skip to main content
Minnesota Department of Health logo
  • Main navigation

    • Home
    • Data, Statistics, and Legislation
    • Diseases and Conditions
    • Health Care Facilities, Providers, and Insurance
    • Healthy Communities, Environment, and Workplaces
    • Individual and Family Health
    • About Us
    • News and Announcements
    • Translated Materials

Main navigation mobile

  • Data, Statistics, and Legislation
  • Diseases and Conditions
  • Health Care Facilities, Providers, and Insurance
  • Healthy Communities, Environment, and Workplaces
  • Individual and Family Health
  • About Us
  • News and Announcements
  • Translated Materials
MDH Logo

Breadcrumb

  1. Home
  2. Data, Statistics and Legislation
Topic Menu

Market Oversight

  • Market Oversight Home
  • MDH Transaction Notices

Related Sites

  • Health Economics Program
  • Prescription Drug Price Transparency
  • Hospital Bed Moratorium
  • Capital Expenditure
  • Provider Cooperative Review

Market Oversight

  • Market Oversight Home
  • MDH Transaction Notices

Related Sites

  • Health Economics Program
  • Prescription Drug Price Transparency
  • Hospital Bed Moratorium
  • Capital Expenditure
  • Provider Cooperative Review
Contact Info
Health Economics Program
651-201-4520
health.hctransactions@state.mn.us

Contact Info

Health Economics Program
651-201-4520
health.hctransactions@state.mn.us

Market Oversight

In addition to conducting research and analysis, the Health Economics Program (HEP) also performs several activities to monitor health care markets and provide oversight in key areas. 

For example, with the adoption of Minnesota Statutes sections 145D.01 and 145D.02, HEP is responsible for receiving notice and specific information prior to the close of certain health care entity transactions. As part of this work, HEP supports the review functions of the Attorney General’s Office under Minnesota Statutes 145D.01.

Requirements for certain health care entities transactions

The notice and reporting requirements are intended to enable state officials to manage or respond to health care transactions that may be contrary to the public interest or violate antitrust and charities laws. The statute establishes two mechanisms under which health care entities entering transactions (as defined by the law) are required to provide notice and information. 

  • 145D.01: Applies to all transactions where one entity has, or the final entity created by the transaction is expected to have, average revenue of at least $80 million per year. For health care entity transactions subject to this provision, notice and information must be submitted to both the Attorney General’s Office (AGO) and the Minnesota Department of Health (MDH) at least 60 days prior to the proposed completion of the transaction.
  • 145D.02: Applies to all transactions where one entity has, or the final entity created by the transaction is expected to have, average revenue between $10 million and $80 million per year. For health care entity transactions subject to this provision, certain data must be provided to MDH at least 30 days prior to the proposed completion of the transaction (see the Transaction Notices webpage). 

Questions may be directed to the AGO (health.notices@ag.state.mn.us) and MDH (health.hctransactions@state.mn.us).

For email updates, subscribe to the Health Economics Program’s email list. 

Tags
  • economics
Last Updated: 04/25/2024

Get email updates


Minnesota Department of Health logo

Privacy Policy
Equal Opportunity
Translated Materials
Feedback Form
About MDH
Minnesota.gov
  • Facebook
  • Twitter
  • Linked In
  • Instagram
  • Youtube
Minnesota Department of Health Minnesota Department of health print search share facebook instagram linkedin twitter youtube